Senior Director, Non-clinical development

Jonathon Holt, PhD

Jonathon Holt, PhD, DABT, joined atai Life Sciences in 2021.

Previously, Jonathon was Senior Director, Nonclinical Development at Nuventra Pharma Sciences / CATO SMS where he provided consulting services in nonclinical development strategy and program execution.

Prior to that he was Senior Director, Program Management at Intarcia Therapeutics where he was responsible for managing early development programs for all 5 pipeline molecules and the HIV prevention development partnership with the Bill and Melinda Gates Foundation.

Jonathon holds a Bachelor’s degree in Pharmacology and Physiology (with Honors) from Manchester University, a PhD in the Psychopharmacology of Alcohol Addiction from Durham University, and is a diplomate of the American Board of Toxicolog

<<  Back to our team